Express Pharma

Industry backlash may reshape EU compulsory pharma licensing reform: GlobalData

Both Johnson & Johnson and Pfizer criticised the changes by referencing the positive role of patents in incentivising their vaccine production during the COVID-19 pandemic

0 228